Major health threats ranging from the opioid epidemic to Alzheimer’s disease are impacting the pace of medical progress. How can we overcome these challenges to achieve a longer, healthier lifespan? Research!America’s National Health Research Forum will focus on potential solutions in panel discussions Thursday, September 7, 11:30 a.m. – 3:00 p.m. ET, at the Newseum in Washington, D.C. Experts representing academia, patient groups, government, industry and scientific societies will discuss what it will take to make dramatic strides against deadly and debilitating health threats.
Mikael Dolsten, M.D., Ph.D., president of worldwide research & development, Pfizer, will provide keynote remarks.Scott Gottlieb, M.D., commissioner of the Food and Drug Administration, will discuss the agency’s current priorities to advance research and innovation.
The first panel, moderated by Marilyn Serafini, health care policy consultant and former award-winning journalist, will explore the role of research in understanding and addressing the opioid epidemic and other community health threats. Panelists include Governor Charlie Baker (R-MA); Seth Ginsberg, co-founder and president, Global Healthy Living Foundation; The Hon. Patrick Kennedy, U.S. Representative, 1995-2011; Gopal Khanna, director, Agency for Healthcare Research and Quality; Lucinda Maine, Ph.D., R.Ph., executive vice president and CEO, American Association of Colleges of Pharmacy; and Anne Schuchat, M.D., principal deputy director, Centers for Disease Control and Prevention.
Byron Pitts, anchor & chief national correspondent, ABC News, will moderate the second panel that will focus on regulatory science, patient perspectives in research and barriers to innovation. Panelists include Joel W. Beetsch, Ph.D., vice president of global patient advocacy, Celgene Corporation; Nancy Brown, chief executive officer, American Heart Association; Victor Dzau, M.D., president, National Academy of Medicine; Mark B. McClellan, M.D., Ph.D., MPA, director, Duke-Robert J. Margolis, MD, Center for Health Policy, Duke University; Joe V. Selby, M.D., MPH, director, Patient-Centered Outcomes Research Institute; and Scott Whitaker, president and CEO, AdvaMed.
The third panel, moderated by Jeanne Cummings, deputy bureau chief, Wall Street Journal, Washington, will look at what it would take to achieve a world without disease. Can we marshal the resources, brainpower and policies to prevent and halt the progression of disease? Ann Cary, RN, MPH, Ph.D., FNAP, dean, University of Missouri-Kansas City School of Nursing and Health Studies; Francis S. Collins, M.D., Ph.D., director, National Institutes of Health; Mikael Dolsten, M.D., Ph.D., president of worldwide research & development, Pfizer; William N. Hait, M.D., Ph.D., global head, Janssen Research & Development, Janssen Pharmaceutical Companies of Johnson & Johnson; Iris Loew-Friedrich, M.D., chief medical officer, UCB; David E. Neal, CBE, FMedSci FRCS, senior vice president of global academic research, Elsevier; and Gary Reedy, chief executive officer, American Cancer Society are the panelists.
Pfizer Inc is the lead sponsor of the event. Panel sponsors include AdvaMed, Amgen, Celgene Corporation, Elsevier, Janssen Pharmaceutical Companies of Johnson and Johnson, PCORI and UCB. For more information and a full list of sponsors, visit researchamerica.org/forum.